Document Search

October 16, 2003 Meeting of the Science Advisory Board's Developmental and Reproductive Toxicant (DART) Identification Committee

Request for information on Rosuvastatin calcium to be considered by the OEHHA Science Advisory Board's Carcinogen Identification Committee.

Six chemicals under consideration for possible listing as known to cause cancer via the Authoritative Bodies mechanism: Request for relevant information.

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Methyl Parathion.

Background materials for CIC consultation on OEHHA's proposed acrylamide workplan.

OEHHA adopted the WHO97 Toxicity Equivalency Factors (TEFWHO-97) for polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs), and for dioxin-like polychlorinated biphenyls (PCBs) which were derived by the World Health Organization.  The Scientific Review Panel reviewed and endorsed the equivalency factors at its June 20, 2003 meeting.

OEHHA adopted revised Toxicity Equivalency Factors (TEF WHO-97) for PCDDs, PCDFs, and Dioxin-Like PCBs. 

Notice of intent to list chemical; extension of public comment period: fumonisin B₁

Notice of Intent to List as known to cause cancer under the authoritative bodies mechanism: Fumonisin B₁

The proposed acrylamide work plan outlines four different actions that will provide guidance on the applicability of Proposition 65 to foods.